-
DAC for a single-cell multi-omic atlas of nodal B-cell non-Hodgkin lymphomas
Dac
EGAC50000000226
-
Genomic Alterations and Transcriptional Phenotypes in Circulating Tumor DNA and Matched Metastatic Tumor
Study
phs003689
-
BPH Tissues for Cell Culture and Analysis - A Patient-Derived Xenograft Model Using Benign Prostatic Tissues
Study
phs003692
-
Patient-Derived Breast Cancer Organoid Study
Study
phs002722
-
Prostate Cancer Upgrading Reference Set
Study
phs003670
-
Whole Exome and RNA Sequencing of 22 Patient-Derived Xenografts from Estrogen Receptor-Positive Breast Cancers
Study
phs003324
-
NCI Cancer Model Development for the Human Cancer Model Initiative (HCMI)
Study
phs001486
-
IMPRESS: Improved methylation profiling using restriction enzymes and smMIP sequencing, combined with a new biomarker panel, creating a multi-cancer detection assay
Study
EGAS50000000624
-
Tumor Profiler Melanoma Study
Study
EGAS50000000599
-
BIOMIROX
Dataset
EGAD50000000443
-
DAC for Early detection of ovarian cancer using cell-free DNA fragmentomes and protein biomarkers
Dac
EGAC50000000332
-
Sensitive urothelial cancer detection via high volume urine DNA analysis
Study
EGAS50000000630
-
Sensitive urothelial cancer detection via high volume urine DNA analysis
Dataset
EGAD50000000891
-
Genomic Profiling of Pediatric Tumors by Cell Free DNA Sequencing
Study
EGAS50000000072
-
WES dataset for cfDNA cohort
Dataset
EGAD50000000103
-
WGS data for cfDNA cohort
Dataset
EGAD50000000102
-
cfDNA dataset for cfDNA cohort
Dataset
EGAD50000000104
-
cfDNA dataset with whole genome sequencing for cfDNA cohort
Dataset
EGAD50000000666
-
cfDNA dataset with expanded panel for cfDNA cohort
Dataset
EGAD50000000667
-
Long-read-transcriptome-sequencing of CLL and MDS patients uncovers common molecular effects of SF3B1 mutations
Study
EGAS50000000053
-
Early and Late Onset Colorectal Cancer Genomic Data
Dataset
EGAD50000000774
-
Genomic Data Access Committee for Early and Late Onset Colorectal Cancer Study
Dac
EGAC50000000359
-
Ultra-sensitive ctDNA monitoring required for predicting response and resistance to immunotherapy in advanced melanoma
Study
EGAS50000000550
-
DNA-Sequencing of Baseline Plasma From the Phase III Alliance A031201 Trial
Study
phs003325
-
A Comprehensive Genomic Study of Pediatric Malignancy
Study
phs001928